HK1246682A1 - 含有ala類的病毒感染症預防/治療劑 - Google Patents

含有ala類的病毒感染症預防/治療劑

Info

Publication number
HK1246682A1
HK1246682A1 HK18106308.4A HK18106308A HK1246682A1 HK 1246682 A1 HK1246682 A1 HK 1246682A1 HK 18106308 A HK18106308 A HK 18106308A HK 1246682 A1 HK1246682 A1 HK 1246682A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
virus infections
comprises ala
ala compound
Prior art date
Application number
HK18106308.4A
Other languages
English (en)
Inventor
Tohru Tanaka
Motowo Nakajima
Takeshi Hara
Original Assignee
Sbi Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbi Pharmaceuticals Co Ltd filed Critical Sbi Pharmaceuticals Co Ltd
Publication of HK1246682A1 publication Critical patent/HK1246682A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18106308.4A 2015-04-10 2018-05-15 含有ala類的病毒感染症預防/治療劑 HK1246682A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015080703 2015-04-10
PCT/JP2016/001609 WO2016163082A1 (ja) 2015-04-10 2016-03-18 Ａｌａ類を含むウイルス感染症予防／治療剤

Publications (1)

Publication Number Publication Date
HK1246682A1 true HK1246682A1 (zh) 2018-09-14

Family

ID=57071889

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18105124.8A HK1245648A1 (zh) 2015-04-10 2018-04-19 含有ala類的病毒感染症預防／治療劑
HK18106308.4A HK1246682A1 (zh) 2015-04-10 2018-05-15 含有ala類的病毒感染症預防/治療劑

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK18105124.8A HK1245648A1 (zh) 2015-04-10 2018-04-19 含有ala類的病毒感染症預防／治療劑

Country Status (6)

Country Link
US (1) US20180125805A1 (zh)
EP (1) EP3281629A1 (zh)
JP (1) JPWO2016163082A1 (zh)
CN (1) CN107405323A (zh)
HK (2) HK1245648A1 (zh)
WO (1) WO2016163082A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019085382A (ja) * 2017-11-10 2019-06-06 ネオファーマジャパン株式会社 植物ウイルス病の予防又は治療剤
EP3960241A4 (en) 2019-04-26 2023-06-07 Neopharma Japan Co., Ltd. THERAPEUTIC AGENT FOR FLAVIVIRUS INFECTION
WO2021132626A1 (ja) * 2019-12-27 2021-07-01 国立大学法人北海道大学 豚熱の治療及び／又は予防剤
EP4140479A4 (en) * 2020-04-22 2024-05-29 Neopharma Japan Co Ltd THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)
WO2022182852A1 (en) * 2021-02-24 2022-09-01 MoxxiTech, LLC Compositions and methods for treating canine parvovirus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
CN104487067B (zh) * 2012-07-19 2017-09-01 思佰益药业股份有限公司 流行性感冒病毒感染症的预防·治疗剂

Also Published As

Publication number Publication date
US20180125805A1 (en) 2018-05-10
EP3281629A1 (en) 2018-02-14
HK1245648A1 (zh) 2018-08-31
WO2016163082A1 (ja) 2016-10-13
CN107405323A (zh) 2017-11-28
JPWO2016163082A1 (ja) 2017-12-07

Similar Documents

Publication Publication Date Title
SI3349758T1 (sl) Postopki za zdravljenje okužb z virusom arenaviridae
ZA201708039B (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
GB201511790D0 (en) Pharmaceutical compound
IL280327A (en) Thiazolide compounds for the treatment of viral infections
HK1246682A1 (zh) 含有ala類的病毒感染症預防/治療劑
GB201516411D0 (en) Pharmaceutical compound
EP3366299A4 (en) MEANS OF PREVENTING INFECTIONS FOR SMALL CHILDREN
EP3315131A4 (en) THERAPEUTIC AGENT AGAINST FIBROSIS
HK1250627A1 (zh) 用於治療hcv的固體藥物組合物
HK1255203A1 (zh) 用於治療hcv的固體藥物組合物
SG11201708818VA (en) Pharmaceutical compound
TWI562774B (en) Sodium methylarsonate as glycorpotien infections for virus
EP3370197A4 (en) AGENTS SYSTEM
PL3160263T3 (pl) Kompozycje do zapobiegania zakażeniom
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
EP3100726A4 (en) Therapeutic or prophylactic agent for multiple sclerosis
EP3354271A4 (en) Agent for treating arthrological diseases
EP3355695A4 (en) SYSTEM FOR THE PREVENTION OF INFECTION DISEASES
EP3290048A4 (en) Immunity-inducing agent
SG11201708817XA (en) Pharmaceutical compound
GB201507883D0 (en) Pharmaceutical compound
GB201502156D0 (en) Pharmaceutical compound